Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
Saved in:
| Main Authors: | Cai Weiran, Zhang Zhijun, Shi Chenyan, Sun Ru, Ju Han, Dong Xuelin, Teng Lei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-08-01
|
| Series: | Open Life Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/biol-2025-1143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TLR2 promotes the progression of diabetes mellitus with atherosclerosis via activating NLRP3 inflammasome and MyD88/NF-κB signaling pathway
by: Sisi Chen, et al.
Published: (2025-05-01) -
Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway
by: Huan-Huan Li, et al.
Published: (2025-05-01) -
Angiotensin converting enzyme 2 activation improves allergic rhinitis and suppresses Th2 cytokine release
by: Xiuying Sun, et al.
Published: (2023-01-01) -
CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
by: YaoMing Zheng, et al.
Published: (2025-01-01) -
Use of bidirectional Mendelian randomization to unveil the association between antibody-mediated immune responses to infectious agents and allergic rhinitis
by: Wencan Cao, et al.
Published: (2025-12-01)